Ji Wang - Jinhe Biotechnology Deputy Mang
| 002688 Stock | 4.59 0.04 0.88% |
Executive
Ji Wang is Deputy Mang of Jinhe Biotechnology Co
| Address | 1-7-2 Building 27, Dalian, China, 116023 |
| Web | https://www.jinhe.com.cn |
Jinhe Biotechnology Management Efficiency
The company has return on total asset (ROA) of 0.0223 % which means that it generated a profit of $0.0223 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0371 %, meaning that it generated $0.0371 on every $100 dollars invested by stockholders. Jinhe Biotechnology's management efficiency ratios could be used to measure how well Jinhe Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. At present, Jinhe Biotechnology's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 3.6 B, whereas Non Currrent Assets Other are forecasted to decline to about 58.5 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Yonghong Ma | China Railway Group | 58 | |
| Xueqing Guan | Industrial and Commercial | 61 | |
| Liurong Sheng | China Construction Bank | 59 | |
| Bresson Xu | Industrial and Commercial | N/A | |
| Wei Fang | PetroChina Co Ltd | N/A | |
| FCS FCIS | China Mobile Limited | N/A | |
| Jing Jing | China Railway Construction | 52 | |
| Weisheng Yang | PetroChina Co Ltd | 51 | |
| Di Zhang | China Life Insurance | 56 | |
| Li Huang | Industrial and Commercial | 60 | |
| FCS FCIS | China Construction Bank | 47 | |
| Tongwen Jiang | PetroChina Co Ltd | 55 | |
| Jin Hou | China Life Insurance | 44 | |
| Taifeng Xie | Industrial and Commercial | 52 | |
| Lei Wang | China Railway Construction | N/A | |
| Siqing Chen | Industrial and Commercial | 64 | |
| Zou Xin | Industrial and Commercial | N/A | |
| Xusheng Guo | China Petroleum Chemical | 58 | |
| Xie Song | China State Construction | N/A | |
| Jianhua Song | Industrial and Commercial | 59 | |
| Benjamin Deng | Ping An Insurance | 55 | |
Management Performance
| Return On Equity | 0.0371 | ||||
| Return On Asset | 0.0223 |
Jinhe Biotechnology Leadership Team
Elected by the shareholders, the Jinhe Biotechnology's board of directors comprises two types of representatives: Jinhe Biotechnology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Jinhe. The board's role is to monitor Jinhe Biotechnology's management team and ensure that shareholders' interests are well served. Jinhe Biotechnology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Jinhe Biotechnology's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ji Wang, Deputy Mang | ||
| Zhi Wang, Deputy Director | ||
| Changxian Xie, GM Director | ||
| Ying Liu, Deputy Manager | ||
| Manman Lu, Board Director | ||
| Yueqing Wang, Deputy Director | ||
| Yingzhen Guan, Deputy Manager | ||
| You Niu, Financial Director |
Jinhe Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Jinhe Biotechnology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0371 | ||||
| Return On Asset | 0.0223 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 5.14 B | ||||
| Shares Outstanding | 771.69 M | ||||
| Shares Owned By Insiders | 46.09 % | ||||
| Shares Owned By Institutions | 1.23 % | ||||
| Price To Book | 1.58 X | ||||
| Price To Sales | 1.57 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Jinhe Stock
Jinhe Biotechnology financial ratios help investors to determine whether Jinhe Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jinhe with respect to the benefits of owning Jinhe Biotechnology security.